Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol. 2022;24:v1–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

Article  CAS  PubMed  Google Scholar 

Genoud V, Migliorini D. Challenging hurdles of current targeting in glioblastoma: A focus on immunotherapeutic strategies. Int J Mol Sci. 2021;22:3493.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Güven M, Taşpınar F, Denizler-Ebiri FN, Castresana JS, Taşpınar M. The antagonistic effects of temozolomide and trichostatin a combination on MGMT and DNA mismatch repair pathways in Glioblastoma. Med Oncol. 2023;40:223.

Article  PubMed  Google Scholar 

Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133:2485S-2493S.

Article  CAS  PubMed  Google Scholar 

Candido EP, Reeves R, Davie JR. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell. 1978;14:105–13.

Article  CAS  PubMed  Google Scholar 

Salimi V, Shahsavari Z, Safizadeh B, Hosseini A, Khademian N, Tavakoli-Yaraki M. Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment. Lipids Health Dis. 2017;16:208.

Article  PubMed  PubMed Central  Google Scholar 

Xu Z, Tao J, Chen P, Chen L, Sharma S, Wang G, et al. Sodium Butyrate inhibits colorectal cancer cell migration by downregulating Bmi-1 through enhanced miR-200c expression. Mol Nutr Food Res. 2018;62:1700844.

Article  Google Scholar 

Taylor MA, Khathayer F, Ray SK. Quercetin and sodium butyrate synergistically increase apoptosis in rat C6 and human T98G glioblastoma cells through inhibition of autophagy. Neurochem Res. 2019;44:1715–25.

Article  CAS  PubMed  Google Scholar 

Nakagawa H, Sasagawa S, Itoh K. Sodium butyrate induces senescence and inhibits the invasiveness of glioblastoma cells. Oncol Lett. 2017. https://doi.org/10.3892/ol.2017.7518.

Article  PubMed  PubMed Central  Google Scholar 

Çakır T, Güven M, Taşpınar M, Denizler FN, Kartal B. The effect of sodium butyrate on radiosensitivity in glioblastoma cell. Van Med J. 2019;26:550–6.

Article  Google Scholar 

Butler R, Bates GP. Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat Rev Neurosci. 2006;7:784–96.

Article  CAS  PubMed  Google Scholar 

Yang H, Chen D, Cui QC, Yuan X, Dou QP. Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine”, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 2006;66:4758–65.

Article  CAS  PubMed  Google Scholar 

Li X, Zhu G, Yao X, Wang N, Hu R, Kong Q, et al. Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells. Onco Targets Ther. 2018;11:8977–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S-R, Dai Y, Zhao J, Lin L, Wang Y, Wang Y. a mechanistic overview of triptolide and celastrol, natural products from tripterygium wilfordii Hook F. Front Pharmacol. 2018. https://doi.org/10.3389/fphar.2018.00104.

Article  PubMed  PubMed Central  Google Scholar 

Kashyap D, Sharma A, Tuli HS, Sak K, Mukherjee T, Bishayee A. Molecular targets of celastrol in cancer: Recent trends and advancements. Crit Rev Oncol Hematol. 2018;128:70–81.

Article  PubMed  Google Scholar 

Taspinar M, Denizler F, Güven M, Yüksek V, Çetin S, Dede S. The cytotoxic effects of 5-FU and celastrol on glioblastoma. Van Heal Sci J. 2018;11:5–10.

Google Scholar 

Zhu Y, Liu X, Zhao P, Zhao H, Gao W, Wang L. Celastrol suppresses glioma vasculogenic mimicry formation and angiogenesis by blocking the PI3K/Akt/mTOR signaling pathway. Front Pharmacol. 2020. https://doi.org/10.3389/fphar.2020.00025.

Article  PubMed  PubMed Central  Google Scholar 

Kazemi Sefat NA, Mohammadi MM, Hadjati J, Talebi S, Ajami M, Daneshvar H. Sodium butyrate as a histone deacetylase inhibitor affects toll-like receptor 4 expression in colorectal cancer cell lines. Immunol Invest. 2019;48:759–69.

Article  CAS  PubMed  Google Scholar 

Joachimiak R, Kaźnica A, Drewa T. Influence of sodium butyrate on hepatocellular carcinoma (hepG2) and glioblastoma (C6) cell lines in vitro. Acta Pol Pharm. 2007;64:561–3.

CAS  PubMed  Google Scholar 

Wang Z, Zhai Z, Du X. Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells. Exp Ther Med. 2017;14:819–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang S, Tang Y, Cai X, Peng X, Liu X, Zhang L, et al. Celastrol inhibits vasculogenesis by suppressing the VEGF-induced functional activity of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun. 2012;423:467–72.

Article  CAS  PubMed  Google Scholar 

Yan Y, Guo Y, Zhang W, Ma C, Zhang Y, Wang C, et al. Celastrol enhanced the anticancer effect of lapatinib in human hepatocellular carcinoma cells in vitro. J BUON. 2014;19:412–8.

PubMed  Google Scholar 

Ren B, Liu H, Gao H, Liu S, Zhang Z, Fribley AM, et al. Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress/UPR. Oncotarget. 2017;8:93039–50.

Article  PubMed  PubMed Central  Google Scholar 

Cha Z, Cheng J, Xiang H, Qin J, He Y, Peng Z, et al. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway. Cancer Chemother Pharmacol. 2019;84:719–28.

Article  PubMed  Google Scholar 

Zhang R, Chen Z, Wu S-S, Xu J, Kong L-C, Wei P. Celastrol enhances the anti-liver cancer activity of sorafenib. Med Sci Monit. 2019;25:4068–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maysinger D, Moquin A, Choi J, Kodiha M, Stochaj U. Gold nanourchins and celastrol reorganize the nucleo- and cytoskeleton of glioblastoma cells. Nanoscale. 2018;10:1716–26.

Article  CAS  PubMed  Google Scholar 

Tsung AJ, Guda MR, Asuthkar S, Labak CM, Purvis IJ, Lu Y, et al. Methylation regulates HEY1 expression in glioblastoma. Oncotarget. 2017;8:44398–409.

Article  PubMed  PubMed Central  Google Scholar 

Coxhead JM, Williams EA, Mathers JC. DNA mismatch repair status may influence anti-neoplastic effects of butyrate. Biochem Soc Trans. 2005;33:728–9.

Article  CAS  PubMed  Google Scholar 

Sun X, Zhu M-J. Butyrate inhibits indices of colorectal carcinogenesis via enhancing α-ketoglutarate-dependent DNA demethylation of mismatch repair genes. Mol Nutr Food Res. 2018. https://doi.org/10.1002/mnfr.201700932.

Article  PubMed  PubMed Central  Google Scholar 

Bultman SJ, Jobin C. Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite? Cell Host Microbe. 2014;16:143–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cosgrove DE, Cox GS. Effects of sodium butyrate and 5-azacytidine on DNA methylation in human tumor cell lines: variable response to drug treatment and withdrawal. Biochim Biophys Acta. 1990;1087:80–6.

Article  CAS  PubMed  Google Scholar 

Sawa H, Murakami H, Ohshima Y, Sugino T, Nakajyo T, Kisanuki T, et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. Brain Tumor Pathol. 2001;18:109–14.

Article  CAS  PubMed  Google Scholar 

Kannaiyan R, Shanmugam MK, Sethi G. Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett. 2011;303:9–20.

Article  CAS  PubMed  Google Scholar 

Yadav P, Jaswal V, Sharma A, Kashyap D, Tuli HS, Garg VK, et al. Celastrol as a pentacyclic triterpenoid with chemopreventive properties. Pharm Pat Anal. 2018;7:155–67.

Article  CAS  PubMed  Google Scholar 

Liu X, Zhao P, Wang X, Wang L, Zhu Y, Song Y, et al. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res. 2019;38:184.

Article  PubMed